Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
Public ClinicalTrials.gov record NCT05776069. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Modular Trial to Evaluate VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease and Other Bleeding Disorders (VIVID)
Study identification
- NCT ID
- NCT05776069
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Vega Therapeutics, Inc
- Industry
- Enrollment
- 116 participants
Conditions and interventions
Conditions
Interventions
- Placebo Other
- VGA039 Drug
Other · Drug
Eligibility (public fields only)
- Age range
- 12 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 15, 2023
- Primary completion
- Nov 30, 2029
- Completion
- Nov 30, 2029
- Last update posted
- Aug 25, 2025
2023 – 2029
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Orthopedic Institute for Children (UCLA) | Los Angeles | California | 90007 | Recruiting |
| UC Davis Medical Center | Sacramento | California | 95817 | Recruiting |
| University of Colorado School of Medicine | Aurora | Colorado | 80045 | Recruiting |
| Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory | Atlanta | Georgia | 30308 | Recruiting |
| Science 37, Inc. | Morrisville | North Carolina | 27560 | Recruiting |
| Hemophilia Center of Western PA | Pittsburgh | Pennsylvania | 15213 | Recruiting |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Recruiting |
| University of Texas Southwestern | Dallas | Texas | 75235 | Recruiting |
| Washington Center for Bleeding Disorders | Seattle | Washington | 98101 | Recruiting |
| Versiti Comprehensive Center for Bleeding Disorders | Milwaukee | Wisconsin | 53233 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05776069, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 25, 2025 · Synced Apr 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05776069 live on ClinicalTrials.gov.